Cargando…

Renin–angiotensin system inhibitors and clinical outcomes in patients with atrial fibrillation and heart failure: a propensity score-matched study from the Chinese Atrial Fibrillation Registry

OBJECTIVE: The effect of renin–angiotensin system inhibitors (RASIs) in patients with heart failure (HF) and atrial fibrillation (AF) remains unclear. This study aimed to investigate associations between RASI use and all-cause mortality and cardiovascular outcomes in patients with AF and HF. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Jing, He, Liu, Qiao, Qing, Du, Xin, Ma, Chang-Sheng, Dong, Jian-Zeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Retrospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447106/ https://www.ncbi.nlm.nih.gov/pubmed/34521238 http://dx.doi.org/10.1177/03000605211041439

Ejemplares similares

Catheter ablation of atrial fibrillation in patients with autoimmune disease: A propensity score matching study based on the China Atrial Fibrillation Registry
por: Gao, Ming‐Yang, et al.
Publicado: (2023)

The role of the renin–angiotensin system blocking in the management of atrial fibrillation
por: Cliff, Brett, et al.
Publicado: (2012)

Role of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in cryoballoon ablation outcomes for paroxysmal atrial fibrillation
por: Al-Seykal, Ibragim, et al.
Publicado: (2022)

Polymorphisms of Renin-Angiotensin-Aldosterone System Gene in Chinese Han Patients with Nonfamilial Atrial Fibrillation
por: Zhao, Li-qun, et al.
Publicado: (2015)

Cardiac rehabilitation for heart failure and atrial fibrillation: a propensity- matched study
por: Alhotye, Munyra, et al.
Publicado: (2023)

Correction: Polymorphisms of Renin-Angiotensin-Aldosterone System Gene in Chinese Han Patients with Nonfamilial Atrial Fibrillation
Publicado: (2015)

Integrated Care of Atrial Fibrillation Using the ABC (Atrial fibrillation Better Care) Pathway Improves Clinical Outcomes in Chinese Population: An Analysis From the Chinese Atrial Fibrillation Registry
por: Wang, Yu-Feng, et al.
Publicado: (2021)

Control of Anticoagulation Therapy in Patients with Atrial Fibrillation Treated with Warfarin: A Study from the Chinese Atrial Fibrillation Registry
por: Liang, Hai-Feng, et al.
Publicado: (2019)

Age and CHADS(2) Score Predict the Effectiveness of Renin-Angiotensin System Blockers on Primary Prevention of Atrial Fibrillation
por: Hung, Chen-Ying, et al.
Publicado: (2015)

Ablation Versus Medical Therapy for Atrial Fibrillation in the Elderly: A Propensity Score-Matched Comparison
por: Wang, Haixiong, et al.
Publicado: (2019)

Effect of gender on atrial fibrillation ablation outcomes using a propensity score–matched analysis
por: Al-Sadawi, Mohammed, et al.
Publicado: (2023)

Mortality and morbidity in patients with atrial fibrillation and liver cirrhosis
por: Darrat, Yousef H, et al.
Publicado: (2020)

Incidence and predictors of hospitalization in patients with atrial fibrillation: results from the Chinese atrial fibrillation registry study
por: Dong, Zhaojie, et al.
Publicado: (2021)

Thromboembolic risks associated with paroxysmal and persistent atrial fibrillation in Asian patients: a report from the Chinese atrial fibrillation registry
por: Wang, Ying, et al.
Publicado: (2019)

Rationale and design of the Chinese Atrial Fibrillation Registry Study
por: Du, Xin, et al.
Publicado: (2016)

Clinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure
por: Gigli, Lorenzo, et al.
Publicado: (2016)

Inflammatory markers in paroxysmal atrial fibrillation and the protective role of renin-angiotensin-aldosterone system inhibitors
por: ROŞIANU, ŞTEFAN HORIA, et al.
Publicado: (2013)

Impact of renin–angiotensin–aldosterone-system inhibitor drugs on mortality in patients with atrial fibrillation and hypertension
por: Xu, Wei, et al.
Publicado: (2022)

Inhibition of the renin-angiotensin-aldosterone system prevents and cures atrial fibrillation: An overview of systematic reviews
por: Yu, Zhixiang, et al.
Publicado: (2021)

Hypnotics Use Is Associated with Elevated Incident Atrial Fibrillation: A Propensity-Score Matched Analysis of Cohort Study
por: Hu, Xiang, et al.
Publicado: (2022)

Sex Differences in Presentation, Quality of Life, and Treatment in Chinese Atrial Fibrillation Patients: Insights from the China Atrial Fibrillation Registry Study
por: Li, Yan-Ming, et al.
Publicado: (2019)

Burden of atrial fibrillation in patients with rheumatic diseases
por: Khan, Muhammad Zubair, et al.
Publicado: (2021)

Atrial fibrillation episode status and incidence of coronary slow flow: A propensity score-matched analysis
por: Gao, Ya-fang, et al.
Publicado: (2023)

Mortality, stroke, and heart failure in atrial fibrillation cohorts after ablation versus propensity-matched cohorts
por: Jarman, Julian WE, et al.
Publicado: (2017)

Modified Taiwan Atrial Fibrillation Score for the Prediction of Incident Atrial Fibrillation
por: Liao, Jo-Nan, et al.
Publicado: (2022)

Inhibition of renin-angiotensin axis reduces the risk of thrombus formation in the left atrial appendage in patients with hypertension complicated by atrial fibrillation
por: Suo, Ya, et al.
Publicado: (2018)

Atrial fibrillation in heart failure patients: An update on renin–angiotensin–aldosterone system pathway blockade as a therapeutic and prevention target
por: Koniari, Ioanna, et al.
Publicado: (2023)

The Chinese burden of atrial fibrillation review of atrial fibrillation studies in China
por: Song, Jianshu
Publicado: (2022)

Association of atrial fibrillation and clinical outcomes in adults with chronic kidney disease: A propensity score-matched analysis
por: Zhang, Chunxia, et al.
Publicado: (2020)

Cryoballoon ablation for atrial fibrillation in octogenarians: a propensity-score matching comparison with a cohort of younger patients
por: Cecchini, F, et al.
Publicado: (2023)

Association between use of amiodarone for non-valvular atrial fibrillation and patient survival: from the prospective China Atrial Fibrillation Registry
por: Hou, Xiao-Xia, et al.
Publicado: (2021)

Stroke Risk Status, Anticoagulation Treatment, and Quality-of-Life in Chinese Patients with Atrial Fibrillation: China Registry of Atrial Fibrillation (CRAF)
por: Sun, Yihong, et al.
Publicado: (2019)

Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study
por: Zhang, Zhuxin, et al.
Publicado: (2021)

Atrial fibrillation and the risk of myocardial infarction: a nation-wide propensity-matched study
por: Lee, Hye Young, et al.
Publicado: (2017)

Stroke rates before and after ablation of atrial fibrillation and in propensity-matched controls in the UK
por: Jarman, Julian WE, et al.
Publicado: (2017)

Atrial Fibrillation and Heart Failure
por: Bergau, Leonard, et al.
Publicado: (2022)

Clinical and anatomic predictors of need for repeat atrial fibrillation ablation
por: Desai, Yaanik, et al.
Publicado: (2017)

ABC-AF-Stroke score predicts thromboembolism in non-anticoagulated patients following successful atrial fibrillation ablation: a report from the Chinese Atrial Fibrillation Registry
por: Wang, Yufeng, et al.
Publicado: (2023)

Contemporary characteristics, management, and outcomes of patients hospitalized for atrial fibrillation in China: results from the real-world study of Chinese atrial fibrillation registry
por: Zhao, Qing-Yan, et al.
Publicado: (2020)

Angiotensin receptor-neprilysin inhibitor therapy and recurrence of atrial fibrillation after radiofrequency catheter ablation: A propensity-matched cohort study
por: Dong, Youzheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_if9tfopc48s4ctu1hoiu27j2sh